Proton MR spectroscopy of the prostate.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 17709223)

Published in Eur J Radiol on August 20, 2007

Authors

Ullrich G Mueller-Lisse1, Michael K Scherr

Author Affiliations

1: Dept. of Clinical Radiology, Klinikum der Universitaet Muenchen, Standorte Grosshadern und Innenstadt, Ziemssenstrasse 1, D-80336 Muenchen, Germany. ullrich.mueller-lisse@med.uni-muenchen.de

Articles citing this

Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer. J Med Chem (2008) 1.79

Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy. Prostate Cancer Prostatic Dis (2012) 1.42

New agents and techniques for imaging prostate cancer. J Nucl Med (2009) 0.96

PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. Am J Nucl Med Mol Imaging (2012) 0.96

Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue. BMC Clin Pathol (2011) 0.85

Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r. Magn Reson Med (2009) 0.85

Reliable non-invasive measurement of human neurochemistry using proton spectroscopy with an anatomically defined amygdala-specific voxel. Neuroimage (2011) 0.84

Translational Molecular Imaging of Prostate Cancer. Curr Radiol Rep (2013) 0.82

3.0 T proton magnetic resonance spectroscopy of the liver: quantification of choline. World J Gastroenterol (2013) 0.82

Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint. Quant Imaging Med Surg (2013) 0.82

Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo. MAGMA (2008) 0.81

Molecular origin of plasma membrane citrate transporter in human prostate epithelial cells. EMBO Rep (2010) 0.79

Molecular imaging as a tool for translating breast cancer science. Breast Cancer Res (2008) 0.79

Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens. Prostate Int (2014) 0.77